Triple Helix Discovery Engine
Potential BlockBuster Technology and/or Business Model
Pioneers: Triple Helix: New Business Models_Open Innovation, Virtual Organizations, Royalty Aggregators, Etc.
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Massachusetts

Euthymics Bioscience, Inc.

Attachments

*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies _ Depression, Anxiety Disorders, Schizophrenia, Etc
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies (Pharmaceuticals, Drugs, Biotechnology, Biosimilars)
*Industry: Massachusetts
Companies: Acquired_(M&A)

2017: Ethismos Research Inc. Closes Deal to Acquire the Intellectual Property Assets of Euthymics Bioscience Inc.
Cambridge, Massachusetts
Clinical-stage small molecule company focused on CNS disorders and depression, closed a $24M Series A financing (2010)
Euthymics Bioscience, Inc.: Seris A $24M
Euthymics is also developing a second triple reuptake inhibitor, EB-1020, which is in late-stage preclinical research for adult ADHD.
Founded 2009
Participants include Novartis Venture Fund, Venture Investors, H&Q Capital Management and GBS Venture Partners.
The company’s lead product candidate, EB-1010 for depression, is a triple reuptake inhibitor that acts on serotonin, norepinephrine and dopamine in a specific ratio and is given as monotherapy (a single capsule).